139 related articles for article (PubMed ID: 9505197)
21. Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro.
Rose TM; Weiford DM; Gunderson NL; Bruce AG
Cytokine; 1994 Jan; 6(1):48-54. PubMed ID: 8003633
[TBL] [Abstract][Full Text] [Related]
22. Molecular genetics of leukemia inhibitory factor (LIF) and its receptor.
Gough NM
Growth Factors; 1992; 7(3):175-9. PubMed ID: 1457125
[No Abstract] [Full Text] [Related]
23. Leukemia inhibitory factor--a puzzling polyfunctional regulator.
Metcalf D
Growth Factors; 1992; 7(3):169-73. PubMed ID: 1457124
[TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of a leukemia inhibitory factor-independent embryonic stem cell line.
Gendall AR; Dunn AR; Ernst M
Int J Biochem Cell Biol; 1997 May; 29(5):829-40. PubMed ID: 9251250
[TBL] [Abstract][Full Text] [Related]
25. Cytokines which signal through the LIF receptor and their actions in the nervous system.
Murphy M; Dutton R; Koblar S; Cheema S; Bartlett P
Prog Neurobiol; 1997 Aug; 52(5):355-78. PubMed ID: 9304697
[TBL] [Abstract][Full Text] [Related]
26. The unsolved enigmas of leukemia inhibitory factor.
Metcalf D
Stem Cells; 2003; 21(1):5-14. PubMed ID: 12529546
[TBL] [Abstract][Full Text] [Related]
27. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
[TBL] [Abstract][Full Text] [Related]
28. Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways.
Yoshida K; Chambers I; Nichols J; Smith A; Saito M; Yasukawa K; Shoyab M; Taga T; Kishimoto T
Mech Dev; 1994 Feb; 45(2):163-71. PubMed ID: 8199053
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells.
Kasza A; Rogowski K; Kilarski W; Sobota R; Bernas T; Dobrucki J; Travis J; Koj A; Bugno M; Kordula T
Biochem J; 2001 Apr; 355(Pt 2):307-14. PubMed ID: 11284716
[TBL] [Abstract][Full Text] [Related]
30. Structure of the mouse leukaemia inhibitory factor receptor gene: regulated expression of mRNA encoding a soluble receptor isoform from an alternative 5' untranslated region.
Chambers I; Cozens A; Broadbent J; Robertson M; Lee M; Li M; Smith A
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):879-88. PubMed ID: 9396734
[TBL] [Abstract][Full Text] [Related]
31. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
32. Binding interactions of leukemia inhibitory factor and ciliary neurotrophic factor with the different subunits of their high affinity receptors.
Robledo O; Auguste P; Coupey L; Praloran V; Chevalier S; Pouplard A; Gascan H
J Neurochem; 1996 Apr; 66(4):1391-9. PubMed ID: 8627290
[TBL] [Abstract][Full Text] [Related]
33. Leukemia inhibitory factor is an autocrine survival factor for Schwann cells.
Dowsing BJ; Morrison WA; Nicola NA; Starkey GP; Bucci T; Kilpatrick TJ
J Neurochem; 1999 Jul; 73(1):96-104. PubMed ID: 10386959
[TBL] [Abstract][Full Text] [Related]
34. Leukemia inhibitory factor in human reproduction.
Lass A; Weiser W; Munafo A; Loumaye E
Fertil Steril; 2001 Dec; 76(6):1091-6. PubMed ID: 11730732
[TBL] [Abstract][Full Text] [Related]
35. Regulation of neuronal differentiation in human CNS stem cell progeny by leukemia inhibitory factor.
Galli R; Pagano SF; Gritti A; Vescovi AL
Dev Neurosci; 2000; 22(1-2):86-95. PubMed ID: 10657701
[TBL] [Abstract][Full Text] [Related]
36. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival.
Butzkueven H; Zhang JG; Soilu-Hanninen M; Hochrein H; Chionh F; Shipham KA; Emery B; Turnley AM; Petratos S; Ernst M; Bartlett PF; Kilpatrick TJ
Nat Med; 2002 Jun; 8(6):613-9. PubMed ID: 12042813
[TBL] [Abstract][Full Text] [Related]
37. [Leukemia inhibitory factor: a novel cytokine with multiple function].
Wang FS; Wu ZZ
Sheng Li Ke Xue Jin Zhan; 1993 Jan; 24(1):18-22. PubMed ID: 8332863
[No Abstract] [Full Text] [Related]
38. The soluble interleukin-6 receptor.
Rose-John S; Ehlers M; Grötzinger J; Müllberg J
Ann N Y Acad Sci; 1995 Jul; 762():207-20; discussion 220-1. PubMed ID: 7668529
[No Abstract] [Full Text] [Related]
39. Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.
Heymann D; Godard A; Raher S; Bentouimou N; Blanchard F; Cherel M; Hallet MM; Jacques Y
Cytokine; 1996 Mar; 8(3):197-205. PubMed ID: 8833034
[TBL] [Abstract][Full Text] [Related]
40. Production and characterization of monoclonal antibodies against the leukemia inhibitory factor low affinity receptor, gp190.
Pitard V; Taupin JL; Miossec V; Blanchard F; Cransac M; Jollet I; Vernallis A; Hudson K; Godard A; Jacques Y; Moreau JF
J Immunol Methods; 1997 Jul; 205(2):177-90. PubMed ID: 9294600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
